Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Safety and clinical efficacy.

C V Burton

    Neurosurgery
    |September 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Implanted neuroaugmentive spinal devices offer effective therapy for severe pain, particularly in failed back surgery syndrome patients. This study found a 50% good-to-excellent outcome, significantly improving treatment success rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Juvenile discogenic disease.

    Spine·1994
    Same author

    Causes of failure of surgery on the lumbar spine: ten-year follow-up.

    The Mount Sinai journal of medicine, New York·1991
    Same author

    CT evaluation of the failed back surgery syndrome.

    The Orthopedic clinics of North America·1985
    Same author

    Successful surgical management of lateral spinal stenosis.

    Instructional course lectures·1985
    Same author

    High resolution CT scanning: the present and future.

    The Orthopedic clinics of North America·1983
    Same author

    Neurostimulation as used in a large clinical practice.

    Applied neurophysiology·1982
    Same journal

    Microsurgical Evacuation Efficacy and Functional Outcomes in Spontaneous Intracerebral Hemorrhage by Type of Antithrombotic Therapy.

    Neurosurgery·2026
    Same journal

    Neurosurgeons Are Essential in the Interdisciplinary Care of Patients With Brain Metastasis.

    Neurosurgery·2026
    Same journal

    Performance of Risk Scores in Predicting Intracranial Aneurysm Instability.

    Neurosurgery·2026
    Same journal

    Electric-Scooters: An Emerging Source of High-Severity Pediatric Head Trauma.

    Neurosurgery·2026
    Same journal

    Survival After Surgery for Spinal Osteosarcoma and the Role of Chemotherapy and Treatment Sequencing: A National Cohort Multivariable Analysis.

    Neurosurgery·2026
    Same journal

    Safety and Efficacy of 3-Month Versus 6-Month Duration of Dual Antiplatelet Therapy in Pipeline Embolization Treatment of Intracranial Aneurysms.

    Neurosurgery·2026
    See all related articles

    Area of Science:

    • Neurosurgery
    • Pain Management
    • Biomedical Engineering

    Background:

    • Severe pain conditions, especially failed back surgery syndrome, present significant treatment challenges.
    • Current therapeutic options for refractory pain often yield suboptimal outcomes.
    • Implantable neuroaugmentive spinal devices represent an evolving treatment modality.

    Purpose of the Study:

    • To evaluate the efficacy and safety of implanted neuroaugmentive spinal devices in patients with severe pain.
    • To assess treatment outcomes in a cohort predominantly suffering from failed back surgery syndrome.
    • To compare the success rates of neuroaugmentation with existing therapies.

    Main Methods:

    • A retrospective analysis of 198 patients treated with implanted neuroaugmentive spinal devices.

    Related Experiment Videos

  • Application of the devices under conditions of minimal patient risk.
  • Utilized presently developed patient screening techniques to select appropriate candidates.

    • Main Results:

    • Achieved a 50% good-to-excellent outcome in the studied patient population.
    • Demonstrated a significant improvement in treatment success compared to other available therapies.
    • Documented minimal patient risk associated with the device application.

    Conclusions:

    • Implanted neuroaugmentive spinal devices are a reasonable therapeutic option for selected severe pain problems.
    • The observed success rates indicate a substantial advancement in managing complex pain conditions.
    • Future optimization of device utilization holds promise for further enhancing clinical success.